Liver fat percent is associated with metabolic risk factors and the metabolic syndrome in a high-risk vascular cohort

Nutrition and Metabolism

Volumn 7, Issue , 2010, Pages

  Hoenig, Michel R ^a   Cowin, Gary ^b   Buckley, Raymond ^b   McHenery, Christine ^b   Coulthard, Alan ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID COMPOSITION; LIVER FAT PERCENT; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

EID: 77953516015     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-7-50     Document Type: Article

References (18)

1. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients. AL Vlek Y van der Graaf W Spiering FL Visseren, J Hum Hypertens 2008 22 358 365 10.1038/jhh.2008.5 18273039
2. Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease. AL Vlek Y van der Graaf MA Sluman FL Moll FL Visseren SS Group, J Vasc Surg 2009 50 61 69 10.1016/j.jvs.2008.12.070 19223144
3. Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease. AM Wassink Y Van Der Graaf SS Soedamah-Muthu W Spiering F Visseren Smart Study G, Diab Vasc Dis Res 2008 5 114 122 10.3132/dvdr.2008.019 18537099
4. Brevetti G, Laurenzano E, Giugliano G, Lanero S, Brevetti L, Luciano R, Chiariello M, 2010, Nutrition, Metabolism and Cardiovascular Diseases, 20(9), 676-682
5. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. DB Carr KM Utzschneider RL Hull K Kodama BM Retzlaff JD Brunzell JB Shofer BE Fish RH Knopp SE Kahn, Diabetes 2004 53 2087 2094 10.2337/diabetes.53.8.2087 15277390
6. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. CS Fox JM Massaro U Hoffmann KM Pou P Maurovich-Horvat CY Liu RS Vasan JM Murabito JB Meigs LA Cupples RB D'Agostino CJ O'Donnell, Circulation 2007 116 39 48 10.1161/CIRCULATIONAHA.106.675355 17576866 (Pubitemid 47016245)
7. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. WY Fujimoto RW Bergstrom EJ Boyko KW Chen DL Leonetti L Newell-Morris JB Shofer PW Wahl, Diab Care 1999 22 1808 1812 10.2337/diacare.22.11.1808 (Pubitemid 29521866)
8. Measurement of liver fat by magnetic resonance imaging: Relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men. DC Chan GF Watts TW Ng J Hua S Song PH Barrett, Diabetes Obes Metab 2006 8 698 702 10.1111/j.1463-1326.2005.00543.x 17026495
9. Identification and characterization of metabolically benign obesity in humans. N Stefan K Kantartzis J Machann F Schick C Thamer K Rittig B Balletshofer F Machicao A Fritsche HU Haring, Arch Intern Med 2008 168 1609 1616 10.1001/archinte.168.15.1609 18695074
10. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. ATPIII, Circulation 2002 106 3143 3421 12485966
11. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. R Muniyappa S Lee H Chen MJ Quon, Am J Physiol Endocrinol Metab 2008 294 15 26 10.1152/ajpendo.00645.2007 17957034
12. Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes. PA Sarafidis AN Lasaridis PM Nilsson MI Pikilidou PC Stafilas A Kanaki K Kazakos J Yovos GL Bakris, J Hum Hypertens 2007 21 709 716 10.1038/sj.jhh.1002201 17443211
13. A multicompartment body composition technique based on computerized tomography. B Chowdhury L Sjostrom M Alpsten J Kostanty H Kvist R Lofgren, Int J Obes Relat Metab Disord 1994 18 219 234 8044196
14. Effect of Rosiglitazone on Insulin Sensitivity and Body Composition in Type 2 Diabetic Patients. DG Carey GJ Cowin GJ Galloway NP Jones JC Richards N Biswas DM Doddrell, Obesity Res 2002 10 1008 1015 10.1038/oby.2002.137
15. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. GJ Cowin JR Jonsson JD Bauer S Ash A Ali EJ Osland DM Purdie AD Clouston EE Powell GJ Galloway, J Magn Reson Imaging 2008 28 937 945 10.1002/jmri.21542 18821619
16. Insulin resistance: the link between obesity and cardiovascular disease. GM Reaven, Endocrinol Metab Clin North Am 2008 37 581 601 vii-viii 10.1016/j.ecl.2008.06.005 18775353
17. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and international association for the Study of Obesity. KG Alberti RH Eckel SM Grundy PZ Zimmet JI Cleeman KA Donato JC Fruchart WP James CM Loria SC Smith Jr, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
18. Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups. A Misra JS Wasir NK Vikram, Nutrition 2005 21 969 976 15993041